European call for research projects

The most promising projects, wherever they originate from, must be selected and financed. KickCancer also wants to encourage international collaboration between the largest academic research teams and unearth the most creative and innovative projects that would come from smaller teams.

Our European ambition for research in paediatric oncology is shared by two other European organisations, Imagine for Margo (France) and the Kriibskrank Kanner Fondatioun (Luxembourg).

Together, we set up a European call for projects, the FIGHT KIDS CANCER initiative.

While research projects are often only financed nationally, the FIGHT KIDS CANCER initiative finances research projects across all involved countries.

Our first call was launched in December 2019. We received 23 applications from program sponsors emanating from 7 different European countries.

Mid-June, we selected the best 6 projects for a total amount of slightly over 3 million euros (jointly with our partners Imagine for Margo and the Kriibskrank Kanner Fondatioun).

The overall quality of the submissions was excellent, and we are very proud to have selected the following projects with the assistance of internationally renowned independent experts:

- One clinical trial: AsiDNA, in the field of high-grade gliomas, a devastating brain tumour

- Five translational research projects, aiming at improving our understanding and identifying new treatments for the following diseases:

1. ALARM3 for acute myeloid leukaemia (AML)
2. EpiRT for rhabdoid tumours
3. IMAGINE for osteosarcoma
4. POBCORN for high grade gliomas
5. RESTRAIN for neuroblastoma

FIGHT KIDS CANCER calls will be launched annually from now on in order to sustain the creativity of the research teams in paediatric oncology.

The FIGHT KIDS CANCER projects are financed by the amounts fundraised during RUN TO KICK and the equivalent races organised in France and Luxembourg.

European call for research projects

  • Financed: 3 000 000 euros
    More than 85% of your donations go to financing research and supporting our advocacy work, less than 15% go to administration.
  • Duration: 3 years
  • Countries: Europe
  • Disease: All malignancies
  • Status: Ongoing